Kouji Kajinami1, Kazuhisa Tsukamoto2, Shinji Koba3, Ikuo Inoue4, Masashi Yamakawa5, Shigeaki Suzuki6, Tadanori Hamano7, Hidetsugu Saito8, Yoshiro Saito9, Satohiro Masuda10, Takeo Nakayama11, Tomonori Okamura12, Shizuya Yamashita13,14, Tatehiro Kagawa15, Junji Kaneyama16, Akira Kuriyama17, Rumi Tanaka10, Aya Hirata12, Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics
1Department of Cardiology, Kanazawa Medical University, 2Department of Internal Medicine, Teikyo University School of Medicine, 3Division of Cardiology, Department of Medicine, Showa University School of Medicine, 4Department of Endocrinology and Diabetes, Saitama Medical University, 5Department of Endocrinology and Diabetes, Yokohama City University Medical Center, 6Department of Neurology, Keio University School of Medicine, 7Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 8Faculty of Pharmacy, Keio University, 9Division of Medicinal Safety Science, National Institute of Health Sciences, 10Department of Pharmacy, Kyushu University Hospital, 11Graduate School of Medicine and Public Health, Kyoto University, 12Department of Preventive Medicine and Public Health, Keio University School of Medicine, 13Department of Cardiovascular Medicine, Rinku General Medical Center, 14The Institute of Scientific and Industrial Research, Osaka University, 15Division of Hepatology and Gastroenterology, Department of Internal Medicine, Tokai University School of Medicine, 16Department of Cardiovascular Medicine, Tokyo Medical University, 17Emergency and Critical Care Center, Kurashiki Central Hospital
Journal of Atherosclerosis and Thrombosis 27(4): 375-396, 2020.